Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 6, Pages 1579
Publisher
MDPI AG
Online
2020-06-16
DOI
10.3390/cancers12061579
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting DUBs to degrade oncogenic proteins
- (2020) Anjali Cremer et al. BRITISH JOURNAL OF CANCER
- Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
- (2020) Eric K. Rowinsky et al. INVESTIGATIONAL NEW DRUGS
- Re-evaluating the mechanism of action of α,β-unsaturated carbonyl DUB inhibitors b-AP15 and VLX1570: a paradigmatic example of unspecific protein crosslinking with Michael acceptor motif-containing drugs.
- (2020) Jennifer A. Ward et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency
- (2020) Yu-Shui Ma et al. Molecular Therapy-Oncolytics
- The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53
- (2020) Chen Hu et al. Cell Death & Disease
- Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism
- (2020) Nathan J. Schauer et al. Scientific Reports
- Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation
- (2020) Harinder Gill et al. Cancer Medicine
- MDM2 antagonist-loaded targeted micelles in combination with doxorubicin: effective synergism against human glioblastoma via p53 re-activation
- (2019) C. Sarisozen et al. JOURNAL OF DRUG TARGETING
- A Phase 1/2 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed/ Refractory Acute Myeloid Leukemia
- (2019) Anjali Advani et al. CLINICAL CANCER RESEARCH
- A Phase 1b/2 Study of Oprozomib in Patients With Advanced Multiple Myeloma and Waldenström Macroglobulinemia
- (2019) Irene M. Ghobrial et al. CLINICAL CANCER RESEARCH
- Oprozomib, pomalidomide, and dexamethasone in patients with relapsed and/or refractory multiple myeloma
- (2019) Jatin Shah et al. Clinical Lymphoma Myeloma & Leukemia
- Pharmacodynamics and Pharmacokinetics of Proteasome Inhibitors for the Treatment of Multiple Myeloma
- (2019) Muhamed Baljevic et al. Expert Opinion on Drug Metabolism & Toxicology
- A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma
- (2019) Peter Martin et al. LEUKEMIA & LYMPHOMA
- Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress
- (2019) Hiroki Akiyama et al. CANCER LETTERS
- Phase II study of Carfilzomib in Patients with Refractory Renal Cell Carcinoma
- (2019) Elshad Hasanov et al. Clinical Genitourinary Cancer
- Inhibition of UCH-L1 Deubiquitinating Activity with Two Forms of LDN-57444 Has Anti-Invasive Effects in Metastatic Carcinoma Cells
- (2019) Eiji Kobayashi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma
- (2019) Binod Dhakal et al. Blood Cancer Journal
- USP9X Deubiquitylates DVL2 to Regulate WNT Pathway Specification
- (2019) Casey P. Nielsen et al. Cell Reports
- A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia
- (2019) Benjamin K. Tomlinson et al. AMERICAN JOURNAL OF HEMATOLOGY
- Oprozomib in patients with newly diagnosed multiple myeloma
- (2019) Parameswaran Hari et al. Blood Cancer Journal
- Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma
- (2019) Liling Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Curcumin and Cancer
- (2019) Giordano et al. Nutrients
- Discovery of [1,2,3]triazolo[4,5-d]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors
- (2019) Zhenzhen Liu et al. Acta Pharmaceutica Sinica B
- Design, synthesis, and biological evaluation of novel ubiquitin-activating enzyme inhibitors
- (2018) Yukihiro Itoh et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML
- (2018) Ronan T. Swords et al. BLOOD
- The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphoma
- (2018) Korbinian N. Kropp et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Multiple Myeloma Drug Pipeline—2018: A Review of Small Molecules and Their Therapeutic Targets
- (2018) Hanley N. Abramson Clinical Lymphoma Myeloma & Leukemia
- Deubiquitinating enzymes in cancer stem cells: functions and targeted inhibition for cancer therapy
- (2018) Kamini Kaushal et al. DRUG DISCOVERY TODAY
- Identification of small-molecule inhibitors of USP2a
- (2018) Marcin D. Tomala et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors
- (2018) A Craig Lockhart et al. INVESTIGATIONAL NEW DRUGS
- A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
- (2018) Marc L Hyer et al. NATURE MEDICINE
- Vialinin A, an Edible Mushroom-Derived p-Terphenyl Antioxidant, Prevents VEGF-Induced Neovascularization In Vitro and In Vivo
- (2018) Himangshu Sonowal et al. Oxidative Medicine and Cellular Longevity
- K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains
- (2018) Fumiaki Ohtake et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- USP49 participates in the DNA damage response by forming a positive feedback loop with p53
- (2018) Rongfu Tu et al. Cell Death & Disease
- A family of unconventional deubiquitinases with modular chain specificity determinants
- (2018) Thomas Hermanns et al. Nature Communications
- Receptor Tyrosine Kinase Ubiquitination and De-Ubiquitination in Signal Transduction and Receptor Trafficking
- (2018) William Critchley et al. Cells
- Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer
- (2018) Xiaohong Xia et al. Oncogenesis
- UbiHub: a data hub for the explorers of ubiquitination pathways
- (2018) Lihua Liu et al. BIOINFORMATICS
- Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)
- (2018) Gabriel Rinnerthaler et al. BMC CANCER
- Spotlight on Bortezomib: potential in the treatment of hepatocellular carcinoma
- (2018) I-Tao Huang et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- USP28 contributes to the proliferation and metastasis of gastric cancer
- (2018) Li-Juan Zhao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions
- (2017) Jeffry Adiwidjaja et al. Expert Opinion on Drug Metabolism & Toxicology
- Ubiquitin-Specific Protease USP6 Regulates the Stability of the c-Jun Protein
- (2017) Lisheng Li et al. MOLECULAR AND CELLULAR BIOLOGY
- USP7 small-molecule inhibitors interfere with ubiquitin binding
- (2017) Lorna Kategaya et al. NATURE
- Molecular basis of USP7 inhibition by selective small-molecule inhibitors
- (2017) Andrew P. Turnbull et al. NATURE
- Inhibition of USP10 induces degradation of oncogenic FLT3
- (2017) Ellen L Weisberg et al. Nature Chemical Biology
- Cytotoxic effects of 15-deoxy-Δ12,14-prostaglandin J2 alone and in combination with dasatinib against uterine sarcoma in vitro
- (2017) Takako Kawakita et al. Experimental and Therapeutic Medicine
- A novel deubiquitinase inhibitor b-AP15 triggers apoptosis in both androgen receptor-dependent and -independent prostate cancers
- (2017) Jianyu Cai et al. Oncotarget
- WP1130 attenuates cisplatin resistance by decreasing P53 expression in non–small cell lung carcinomas
- (2017) Xiang Wang et al. Oncotarget
- Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1
- (2016) P. G. Richardson et al. BLOOD
- Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients
- (2016) Nancy Levin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Deubiquitination and Stabilization of PD-L1 by CSN5
- (2016) Seung-Oe Lim et al. CANCER CELL
- The Deubiquitinase USP9X Maintains DNA Replication Fork Stability and DNA Damage Checkpoint Responses by Regulating CLASPIN during S-Phase
- (2016) Edel McGarry et al. CANCER RESEARCH
- Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results
- (2016) S. J. Harrison et al. CLINICAL CANCER RESEARCH
- USP9X Controls EGFR Fate by Deubiquitinating the Endocytic Adaptor Eps15
- (2016) Michol Giovanna Savio et al. CURRENT BIOLOGY
- Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models
- (2016) Mindy I. Davis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Effect of a High-Fat Meal on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors or Lymphoma
- (2016) Neeraj Gupta et al. JOURNAL OF CLINICAL PHARMACOLOGY
- MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes
- (2016) Syed Arif Abdul Rehman et al. MOLECULAR CELL
- 53BP1 Integrates DNA Repair and p53-Dependent Cell Fate Decisions via Distinct Mechanisms
- (2016) Raquel Cuella-Martin et al. MOLECULAR CELL
- USP7 is a SUMO deubiquitinase essential for DNA replication
- (2016) Emilio Lecona et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- TGF-β upregulates the translation of USP15 via the PI3K/AKT pathway to promote p53 stability
- (2016) W-T Liu et al. ONCOGENE
- USP6 oncogene promotes Wnt signaling by deubiquitylating Frizzleds
- (2016) Babita Madan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms
- (2016) F Wolfsperger et al. Cell Death & Disease
- Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells
- (2016) A Paulus et al. Blood Cancer Journal
- USP7 is a SUMO deubiquitinase essential for DNA replication
- (2016) Emilio Lecona et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma
- (2016) Yves-Paul Vandewynckel et al. Oncotarget
- The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells
- (2016) Xin Wang et al. Scientific Reports
- Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies
- (2015) L. F. Peterson et al. BLOOD
- WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation
- (2015) Hao Liu et al. CANCER LETTERS
- Abstract LB-257: Discovery and characterization of novel, highly potent and selective USP7 inhibitors
- (2015) Gerald Gavory et al. CANCER RESEARCH
- La FAM fatale: USP9X in development and disease
- (2015) Mariyam Murtaza et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phase I/II Study of Clofarabine, Etoposide, and Mitoxantrone in Patients With Refractory or Relapsed Acute Leukemia
- (2015) Kamal K.S. Abbi et al. Clinical Lymphoma Myeloma & Leukemia
- Overexpression of deubiquitinating enzyme USP28 promoted non-small cell lung cancer growth
- (2015) Lei Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Ubiquitin specific protease 4 positively regulates the WNT/β-catenin signaling in colorectal cancer
- (2015) Sun-Il Yun et al. Molecular Oncology
- The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
- (2015) Muthu Shanmugam et al. MOLECULES
- Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma
- (2015) Tadeusz Robak et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Degradome database: expanding roles of mammalian proteases in life and disease
- (2015) José G. Pérez-Silva et al. NUCLEIC ACIDS RESEARCH
- Deubiquitinase inhibition as a cancer therapeutic strategy
- (2015) Padraig D'Arcy et al. PHARMACOLOGY & THERAPEUTICS
- Layers of DUB regulation
- (2015) Danny D. Sahtoe et al. TRENDS IN BIOCHEMICAL SCIENCES
- Deubiquitinases in cancer
- (2015) Rongbin Wei et al. Oncotarget
- Mutations in USP9X Are Associated with X-Linked Intellectual Disability and Disrupt Neuronal Cell Migration and Growth
- (2014) Claire C. Homan et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: pharmacokinetics, toxicity and preliminary efficacy
- (2014) Jianliang Yang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma
- (2014) Chun-Lin Wang et al. CARCINOGENESIS
- A small natural molecule promotes mitochondrial fusion through inhibition of the deubiquitinase USP30
- (2014) Wen Yue et al. CELL RESEARCH
- Small-Molecule RA-9 Inhibits Proteasome-Associated DUBs and Ovarian Cancer In Vitro and In Vivo via Exacerbating Unfolded Protein Responses
- (2014) K. Coughlin et al. CLINICAL CANCER RESEARCH
- Ubiquitin-specific Peptidase 42 (USP42) Functions to Deubiquitylate Histones and Regulate Transcriptional Activity
- (2014) Andreas K. Hock et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer
- (2014) Markus E. Diefenbacher et al. JOURNAL OF CLINICAL INVESTIGATION
- Synthesis and Structure–Activity Relationship Studies of N-Benzyl-2-phenylpyrimidin-4-amine Derivatives as Potent USP1/UAF1 Deubiquitinase Inhibitors with Anticancer Activity against Nonsmall Cell Lung Cancer
- (2014) Thomas S. Dexheimer et al. JOURNAL OF MEDICINAL CHEMISTRY
- USP11 regulates p53 stability by deubiquitinating p53
- (2014) Jia-ying Ke et al. Journal of Zhejiang University-SCIENCE B
- Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C
- (2014) Katharine L. Sackton et al. NATURE
- A selective USP1–UAF1 inhibitor links deubiquitination to DNA damage responses
- (2014) Qin Liang et al. Nature Chemical Biology
- Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer
- (2014) S. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Screening of DUB activity and specificity by MALDI-TOF mass spectrometry
- (2014) Maria Stella Ritorto et al. Nature Communications
- Vialinin A is a ubiquitin-specific peptidase inhibitor
- (2013) Kiyoshi Okada et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance
- (2013) Z. Tian et al. BLOOD
- The novel proteasome inhibitor carfilzomib induces cell cycle arrest, apoptosis and potentiates the anti-tumour activity of chemotherapy in rituximab-resistant lymphoma
- (2013) Juan J. Gu et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression
- (2013) Chia-Hsin Chan et al. CELL
- The deubiquitylase USP15 stabilizes newly synthesized REST and rescues its expression at mitotic exit
- (2013) Monica Faronato et al. CELL CYCLE
- USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer
- (2013) S. Byun et al. CLINICAL CANCER RESEARCH
- The Proteasome Inhibitor Carfilzomib Functions Independently of p53 to Induce Cytotoxicity and an Atypical NF- B Response in Chronic Lymphocytic Leukemia Cells
- (2013) S. V. Gupta et al. CLINICAL CANCER RESEARCH
- U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma
- (2013) T. M. Herndon et al. CLINICAL CANCER RESEARCH
- Ubiquitin-specific protease 4 promotes TNF-α-induced apoptosis by deubiquitination of RIP1 in head and neck squamous cell carcinoma
- (2013) Xiaozhi Hou et al. FEBS LETTERS
- USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis
- (2013) André M. Oliveira et al. HUMAN PATHOLOGY
- Stabilization of the Transcription Factor Foxp3 by the Deubiquitinase USP7 Increases Treg-Cell-Suppressive Capacity
- (2013) Jorg van Loosdregt et al. IMMUNITY
- Smurf1-Mediated Lys29-Linked Nonproteolytic Polyubiquitination of Axin Negatively Regulates Wnt/ -Catenin Signaling
- (2013) C. Fei et al. MOLECULAR AND CELLULAR BIOLOGY
- The complexity of NF-κB signaling in inflammation and cancer
- (2013) Bastian Hoesel et al. Molecular Cancer
- Mitoxantrone Targets Human Ubiquitin-Specific Peptidase 11 (USP11) and Is a Potent Inhibitor of Pancreatic Cancer Cell Survival
- (2013) Richard A. Burkhart et al. MOLECULAR CANCER RESEARCH
- Deubiquitinase Inhibition of 19S Regulatory Particles by 4-Arylidene Curcumin Analog AC17 Causes NF- B Inhibition and p53 Reactivation in Human Lung Cancer Cells
- (2013) B. Zhou et al. MOLECULAR CANCER THERAPEUTICS
- Small-Molecule Inhibitors of USP1 Target ID1 Degradation in Leukemic Cells
- (2013) H. Mistry et al. MOLECULAR CANCER THERAPEUTICS
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Betulinic Acid Selectively Increases Protein Degradation and Enhances Prostate Cancer-Specific Apoptosis: Possible Role for Inhibition of Deubiquitinase Activity
- (2013) Teresita Reiner et al. PLoS One
- Constitutive Endocytosis and Turnover of the Neuronal Glycine Transporter GlyT2 Is Dependent on Ubiquitination of a C-Terminal Lysine Cluster
- (2013) Jaime de Juan-Sanz et al. PLoS One
- Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
- (2013) Yong S. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- USP28 is a potential prognostic marker for bladder cancer
- (2013) Guiying Guo et al. TUMOR BIOLOGY
- USP2a alters chemotherapeutic response by modulating redox
- (2013) B Benassi et al. Cell Death & Disease
- USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis
- (2013) Y-H Fan et al. Cell Death & Disease
- The Deubiquitinase USP28 Stabilizes LSD1 and Confers Stem-Cell-like Traits to Breast Cancer Cells
- (2013) Yadi Wu et al. Cell Reports
- Deubiquitination of Dishevelled by Usp14 is required for Wnt signaling
- (2013) H Jung et al. Oncogenesis
- The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition
- (2012) Chander Peddaboina et al. BMC CANCER
- A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
- (2012) Dharminder Chauhan et al. CANCER CELL
- Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration
- (2012) Valbona Luga et al. CELL
- Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes
- (2012) Olga A. Issaenko et al. CELL CYCLE
- The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer
- (2012) Jayoung Kim et al. CELL CYCLE
- Discovery of Specific Inhibitors of Human USP7/HAUSP Deubiquitinating Enzyme
- (2012) Céline Reverdy et al. CHEMISTRY & BIOLOGY
- MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy
- (2012) Steffan T Nawrocki et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The way Wnt works: Components and mechanism
- (2012) Kenyi Saito-Diaz et al. GROWTH FACTORS
- Regulation of NF-κB by deubiquitinases
- (2012) Edward W. Harhaj et al. IMMUNOLOGICAL REVIEWS
- The deubiquitinase USP44 is a tumor suppressor that protects against chromosome missegregation
- (2012) Andrew J. Holland et al. JOURNAL OF CLINICAL INVESTIGATION
- Manadosterols A and B, Sulfonated Sterol Dimers Inhibiting the Ubc13–Uev1A Interaction, Isolated from the Marine Sponge Lissodendryx fibrosa
- (2012) Shuntaro Ushiyama et al. JOURNAL OF NATURAL PRODUCTS
- Triggering Fbw7-Mediated Proteasomal Degradation of c-Myc by Oridonin Induces Cell Growth Inhibition and Apoptosis
- (2012) H.-L. Huang et al. MOLECULAR CANCER THERAPEUTICS
- USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma
- (2012) Pieter J A Eichhorn et al. NATURE MEDICINE
- The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation
- (2012) Z Liu et al. ONCOGENE
- Tumours associated with BAP1 mutations
- (2012) Rajmohan Murali et al. PATHOLOGY
- Erioflorin Stabilizes the Tumor Suppressor Pdcd4 by Inhibiting Its Interaction with the E3-ligase β-TrCP1
- (2012) Johanna S. Blees et al. PLoS One
- Oncogenes in Cell Survival and Cell Death
- (2012) J. Shortt et al. Cold Spring Harbor Perspectives in Biology
- Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47
- (2012) Joseph Weinstock et al. ACS Medicinal Chemistry Letters
- Histone Ubiquitination and Deubiquitination in Transcription, DNA Damage Response, and Cancer
- (2012) Jian Cao et al. Frontiers in Oncology
- Receptor Tyrosine Kinases and Targeted Cancer Therapeutics
- (2011) Kenji Takeuchi et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- An Allosteric Inhibitor of the Human Cdc34 Ubiquitin-Conjugating Enzyme
- (2011) Derek F. Ceccarelli et al. CELL
- USP1 Deubiquitinates ID Proteins to Preserve a Mesenchymal Stem Cell Program in Osteosarcoma
- (2011) Samuel A. Williams et al. CELL
- Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13
- (2011) Junli Liu et al. CELL
- Enzymatic Characterisation of USP7 Deubiquitinating activity and Inhibition
- (2011) Jonathan D. Wrigley et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of Aurora B
- (2011) Renske J. van Leuken et al. CELL CYCLE
- USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A
- (2011) Xiao-yong Zhang et al. CELL CYCLE
- DUBs and cancer: The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors
- (2011) Sajjad Hussain et al. CELL CYCLE
- Control of AIF-mediated cell death by antagonistic functions of CHIP ubiquitin E3 ligase and USP2 deubiquitinating enzyme
- (2011) K H Oh et al. CELL DEATH AND DIFFERENTIATION
- A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination
- (2011) Vaibhav Kapuria et al. CELLULAR SIGNALLING
- Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes
- (2011) Mikael Altun et al. CHEMISTRY & BIOLOGY
- Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells
- (2011) Junjun Chen et al. CHEMISTRY & BIOLOGY
- In Vitro and In Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells
- (2011) Dharminder Chauhan et al. CLINICAL CANCER RESEARCH
- Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
- (2011) B. C. Potts et al. CURRENT CANCER DRUG TARGETS
- Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
- (2011) D. Chen et al. CURRENT CANCER DRUG TARGETS
- Regulation of p53 stability and function by the deubiquitinating enzyme USP42
- (2011) Andreas K Hock et al. EMBO JOURNAL
- JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress
- (2011) Juhong Liu et al. EMBO JOURNAL
- USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1
- (2011) Xinna Zhang et al. EMBO JOURNAL
- USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation
- (2011) Jean-Hugues Guervilly et al. HUMAN MOLECULAR GENETICS
- An RNAi screen identifies USP2 as a factor required for TNF-α-induced NF-κB signaling
- (2011) Marie Metzig et al. INTERNATIONAL JOURNAL OF CANCER
- Ubiquitin-specific Cysteine Protease 2a (USP2a) Regulates the Stability of Aurora-A
- (2011) Yan Shi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Usp18 Regulates Epidermal Growth Factor (EGF) Receptor Expression and Cancer Cell Survival via MicroRNA-7
- (2011) Jason E. Duex et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Polyubiquitin Linkage Profiles in Three Models of Proteolytic Stress Suggest the Etiology of Alzheimer Disease
- (2011) Eric B. Dammer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Ubiquitin-Specific Protease USP34 Regulates Axin Stability and Wnt/ -Catenin Signaling
- (2011) T. T. H. Lui et al. MOLECULAR AND CELLULAR BIOLOGY
- Deubiquitinase USP37 Is Activated by CDK2 to Antagonize APCCDH1 and Promote S Phase Entry
- (2011) XiaoDong Huang et al. MOLECULAR CELL
- USP15 is a deubiquitylating enzyme for receptor-activated SMADs
- (2011) Masafumi Inui et al. NATURE CELL BIOLOGY
- The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
- (2011) Matthew Bott et al. NATURE GENETICS
- Germline mutations in BAP1 predispose to melanocytic tumors
- (2011) Thomas Wiesner et al. NATURE GENETICS
- Germline BAP1 mutations predispose to malignant mesothelioma
- (2011) Joseph R Testa et al. NATURE GENETICS
- Inhibition of proteasome deubiquitinating activity as a new cancer therapy
- (2011) Pádraig D'Arcy et al. NATURE MEDICINE
- USP10 deubiquitylates the histone variant H2A.Z and both are required for androgen receptor-mediated gene activation
- (2011) Ryan Draker et al. NUCLEIC ACIDS RESEARCH
- Deubiquitinases in cancer: new functions and therapeutic options
- (2011) J M Fraile et al. ONCOGENE
- Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression
- (2011) F Pareja et al. ONCOGENE
- Proteolytic networks in cancer
- (2011) Steven D. Mason et al. TRENDS IN CELL BIOLOGY
- Discovery of Mdm2-MdmX E3 Ligase Inhibitors Using a Cell-Based Ubiquitination Assay
- (2011) A. G. Herman et al. Cancer Discovery
- Proteasome inhibitors in cancer therapy
- (2011) Lisa J. Crawford et al. Journal of Cell Communication and Signaling
- A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma
- (2010) D. Chauhan et al. BLOOD
- The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma
- (2010) G. W. Xu et al. BLOOD
- Pharmacologic Inhibition of the Anaphase-Promoting Complex Induces A Spindle Checkpoint-Dependent Mitotic Arrest in the Absence of Spindle Damage
- (2010) Xing Zeng et al. CANCER CELL
- The Deubiquitinating Enzyme USP17 Is Highly Expressed in Tumor Biopsies, Is Cell Cycle Regulated, and Is Required for G1-S Progression
- (2010) C. McFarlane et al. CANCER RESEARCH
- Deubiquitinase Inhibition by Small-Molecule WP1130 Triggers Aggresome Formation and Tumor Cell Apoptosis
- (2010) V. Kapuria et al. CANCER RESEARCH
- USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
- (2010) Jian Yuan et al. CELL
- Synthesis and Biological Evaluation of 9-Oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile Analogues as Potential Inhibitors of Deubiquitinating Enzymes
- (2010) Matteo Colombo et al. ChemMedChem
- The ubiquitous role of ubiquitin in the DNA damage response
- (2010) Abdallah Al-Hakim et al. DNA REPAIR
- Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor
- (2010) Goedele N Maertens et al. EMBO JOURNAL
- The role of deubiquitinating enzymes in chromatin regulation
- (2010) Boyko S. Atanassov et al. FEBS LETTERS
- The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome
- (2010) E. J. Song et al. GENES & DEVELOPMENT
- Regulation of Histone H2A and H2B Deubiquitination andXenopusDevelopment by USP12 and USP46
- (2010) Heui-Yun Joo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DJ-1 Enhances Cell Survival through the Binding of Cezanne, a Negative Regulator of NF-κB
- (2010) R. Sean McNally et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genome-Wide Association Studies of Cancer
- (2010) Zsofia K. Stadler et al. JOURNAL OF CLINICAL ONCOLOGY
- MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling
- (2010) Jian Liang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9–driven antiinflammatory cytokine production
- (2010) Jose M. González-Navajas et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Small-Molecule Inhibitor of MDMX Activates p53 and Induces Apoptosis
- (2010) H. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Enhancement of proteasome activity by a small-molecule inhibitor of USP14
- (2010) Byung-Hoon Lee et al. NATURE
- Diverse somatic mutation patterns and pathway alterations in human cancers
- (2010) Zhengyan Kan et al. NATURE
- An allosteric inhibitor of substrate recognition by the SCFCdc4 ubiquitin ligase
- (2010) Stephen Orlicky et al. NATURE BIOTECHNOLOGY
- Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase
- (2010) Mariam Aghajan et al. NATURE BIOTECHNOLOGY
- Emerging principles in protease-based drug discovery
- (2010) Marcin Drag et al. NATURE REVIEWS DRUG DISCOVERY
- Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury
- (2010) Hao Liu et al. NEUROBIOLOGY OF DISEASE
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
- (2010) J. W. Harbour et al. SCIENCE
- Regulation and Cellular Roles of Ubiquitin-Specific Deubiquitinating Enzymes
- (2009) Francisca E. Reyes-Turcu et al. Annual Review of Biochemistry
- The NF- B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
- (2009) U. Novak et al. BLOOD
- FAM/USP9x, a Deubiquitinating Enzyme Essential for TGFβ Signaling, Controls Smad4 Monoubiquitination
- (2009) Sirio Dupont et al. CELL
- Defining the Human Deubiquitinating Enzyme Interaction Landscape
- (2009) Mathew E. Sowa et al. CELL
- Modes of p53 Regulation
- (2009) Jan-Philipp Kruse et al. CELL
- CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes
- (2009) S-C Sun CELL DEATH AND DIFFERENTIATION
- A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies
- (2009) O. A. O'Connor et al. CLINICAL CANCER RESEARCH
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- The Isopeptidase Inhibitor G5 Triggers a Caspase-independent Necrotic Death in Cells Resistant to Apoptosis
- (2009) Alessandra Fontanini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The 26 S Proteasome: From Basic Mechanisms to Drug Targeting
- (2009) Ami Navon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ubiquitin-specific Peptidase 21 Inhibits Tumor Necrosis Factor α-induced Nuclear Factor κB Activation via Binding to and Deubiquitinating Receptor-interacting Protein 1
- (2009) Gufeng Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian Families with high risk of breast cancer
- (2009) Frédéric Guénard et al. JOURNAL OF HUMAN GENETICS
- Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)
- (2009) Han-Jie Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Association of C-Terminal Ubiquitin Hydrolase BRCA1-Associated Protein 1 with Cell Cycle Regulator Host Cell Factor 1
- (2009) S. Misaghi et al. MOLECULAR AND CELLULAR BIOLOGY
- RNA Interference Screen Identifies Usp18 as a Regulator of Epidermal Growth Factor Receptor Synthesis
- (2009) Jason E. Duex et al. MOLECULAR BIOLOGY OF THE CELL
- Wnt/Planar cell polarity signaling: A new paradigm for cancer therapy
- (2009) Y. Wang MOLECULAR CANCER THERAPEUTICS
- Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
- (2009) F. Colland et al. MOLECULAR CANCER THERAPEUTICS
- Suppression of Cancer Cell Growth by Promoting Cyclin D1 Degradation
- (2009) Jing Shan et al. MOLECULAR CELL
- Nonproteolytic Functions of Ubiquitin in Cell Signaling
- (2009) Zhijian J. Chen et al. MOLECULAR CELL
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
- (2009) Sohrab P. Shah et al. NATURE
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- Breaking the chains: structure and function of the deubiquitinases
- (2009) David Komander et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Inactivation of HAUSP in vivo modulates p53 function
- (2009) N Kon et al. ONCOGENE
- MdmX is a substrate for the deubiquitinating enzyme USP2a
- (2009) N Allende-Vega et al. ONCOGENE
- Regulation of ErbB2 Receptor Status by the Proteasomal DUB POH1
- (2009) Han Liu et al. PLoS One
- A novel small-molecule inhibitor of NF-κB signaling
- (2008) Hiroto Nakajima et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Control of AMPK-related kinases by USP9X and atypical Lys29/Lys33-linked polyubiquitin chains
- (2008) Abdallah K. Al-Hakim et al. BIOCHEMICAL JOURNAL
- The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation
- (2008) Lianyun Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Leucettamol A: A new inhibitor of Ubc13-Uev1A interaction isolated from a marine sponge, Leucetta aff. microrhaphis
- (2008) Sachiko Tsukamoto et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting the p27 E3 ligase SCFSkp2 results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy
- (2008) Q. Chen et al. BLOOD
- HSV ICP0 recruits USP7 to modulate TLR-mediated innate response
- (2008) S. Daubeuf et al. BLOOD
- Shared Principles in NF-κB Signaling
- (2008) Matthew S. Hayden et al. CELL
- Curcumin: From ancient medicine to current clinical trials
- (2008) H. Hatcher et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Atypical ubiquitin chains: new molecular signals. ‘Protein Modifications: Beyond the Usual Suspects’ Review Series
- (2008) Fumiyo Ikeda et al. EMBO REPORTS
- NF-κB Suppression by the Deubiquitinating Enzyme Cezanne
- (2008) Karine Enesa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of p97-dependent Protein Degradation by Eeyarestatin I
- (2008) Qiuyan Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53
- (2008) Saurabh Dayal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Proteases: Multifunctional Enzymes in Life and Disease
- (2008) Carlos López-Otín et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting tumor cells expressing p53 with a water-soluble inhibitor of Hdm2
- (2008) J. Kitagaki et al. MOLECULAR CANCER THERAPEUTICS
- The Putative Cancer Stem Cell Marker USP22 Is a Subunit of the Human SAGA Complex Required for Activated Transcription and Cell-Cycle Progression
- (2008) Xiao-Yong Zhang et al. MOLECULAR CELL
- The deubiquitinylation and localization of PTEN are regulated by a HAUSP–PML network
- (2008) Min Sup Song et al. NATURE
- Is NF-κB a good target for cancer therapy? Hopes and pitfalls
- (2008) Véronique Baud et al. NATURE REVIEWS DRUG DISCOVERY
- Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
- (2008) S. Shangary et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities
- (2008) Benjamin Nicholson et al. PROTEIN SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now